Journal of Clinical Endocrinology & Metabolism, Vol 77, 949-955, Copyright © 1993 by Endocrine Society

ARTICLES

Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry

C Messa, WG Goodman, CK Hoh, Y Choi, AR Nissenson, IB Salusky, ME Phelps and RA Hawkins
Division of Nuclear Medicine and Biophysics, UCLA School of Medicine 90024-1721.

We evaluated the bone metabolic activity in patients with renal osteodystrophy using positron emission tomography and [18F]fluoride ion. Eight patients had secondary hyperparathyroidism (HPT), and three had low-turnover bone disease. Eleven normal subjects were also studied, and three of the eight HPT patients were reevaluated after therapy. A rate constant (K) describing the net transport of [18F] fluoride ion into a bound compartment in bone was calculated using both a three-compartment model and Patlak graphical analysis. Values of K were compared with biochemical data and with histomorphometric indices. The results indicate that K is significantly higher (P < 0.01) in HPT patients than in normal subjects and patients with low-turnover bone disease. Values of K correlated with serum alkaline phosphatase (r = 0.81) and PTH (r = 0.93) levels and with histomorphometric indices of bone formation rate (r = 0.84, P < 0.01) and eroded perimeter (r = 0.77, P < 0.05). Values of K decreased by 40 and 30%, respectively, in two patients who underwent parathyroidectomy and medical therapy. Positron emission tomography studies of bone using [18F]fluoride ion can differentiate low turnover from high turnover lesions of renal osteodystrophy and provide quantitative estimates of bone cell activity that correlate with histomorphometric data.

This article has been cited by other articles:

				K. Uchida, H. Nakajima, T. Miyazaki, T. Yayama, H. Kawahara, S. Kobayashi, T. Tsuchida, H. Okazawa, Y. Fujibayashi, and H. Baba Effects of Alendronate on Bone Metabolism in Glucocorticoid-Induced Osteoporosis Measured by 18F-Fluoride PET: A Prospective Study J. Nucl. Med., November 1, 2009; 50(11): 1808 - 1814. [Abstract] [Full Text] [PDF]

				G. M. Blake, M. L. Frost, and I. Fogelman Quantitative Radionuclide Studies of Bone J. Nucl. Med., November 1, 2009; 50(11): 1747 - 1750. [Full Text] [PDF]

				M. L. Frost, G. M. Blake, S.-J. Park-Holohan, G. J.R. Cook, K. M. Curran, P. K. Marsden, and I. Fogelman Long-Term Precision of 18F-Fluoride PET Skeletal Kinetic Studies in the Assessment of Bone Metabolism J. Nucl. Med., May 1, 2008; 49(5): 700 - 707. [Abstract] [Full Text] [PDF]

				W. K. Hsu, M. S. Virk, B. T. Feeley, D. B. Stout, A. F. Chatziioannou, and J. R. Lieberman Characterization of Osteolytic, Osteoblastic, and Mixed Lesions in a Prostate Cancer Mouse Model Using 18F-FDG and 18F-Fluoride PET/CT J. Nucl. Med., March 1, 2008; 49(3): 414 - 421. [Abstract] [Full Text] [PDF]

				F. D. Grant, F. H. Fahey, A. B. Packard, R. T. Davis, A. Alavi, and S. T. Treves Skeletal PET with 18F-Fluoride: Applying New Technology to an Old Tracer J. Nucl. Med., January 1, 2008; 49(1): 68 - 78. [Abstract] [Full Text] [PDF]

				R. L. Bridges, C. R. Wiley, J. C. Christian, and A. P. Strohm An Introduction to Na18F Bone Scintigraphy: Basic Principles, Advanced Imaging Concepts, and Case Examples J. Nucl. Med. Technol., June 1, 2007; 35(2): 64 - 76. [Abstract] [Full Text] [PDF]

				M. Piert, T. T. Zittel, M. Jahn, A. Stahlschmidt, G. A. Becker, and H.-J. Machulla Increased Sensitivity in Detection of a Porcine High-Turnover Osteopenia After Total Gastrectomy by Dynamic 18F-Fluoride Ion PET and Quantitative CT J. Nucl. Med., January 1, 2003; 44(1): 117 - 124. [Abstract] [Full Text] [PDF]

				M. Piert, T. T. Zittel, G. A. Becker, M. Jahn, A. Stahlschmidt, G. Maier, H.-J. Machulla, and R. Bares Assessment of Porcine Bone Metabolism by Dynamic [18F]Fluoride Ion PET: Correlation with Bone Histomorphometry J. Nucl. Med., July 1, 2001; 42(7): 1091 - 1100. [Abstract] [Full Text] [PDF]